Cart (0 Items)
Your cart is currently empty.
View ProductsStable Isotope Labeled Adalimumab Biosimilar – Anti-TNF alpha mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Isotope Labeled Adalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade |
|---|---|
| Source | DrugBank DB00051 |
| Species | Human |
| Expression system | Mammalian cells |
| Molecular weight | 144kDa |
| Purity | >90% |
| Buffer | PBS pH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Storage condition | 4°C for short term; -20°C for long term |
| Brand | ProteoGenix |
| Applications | MS |
| Aliases /Synonyms | Adalimumab |
| Reference | PX-TA1001-SIL |
| Related Products | PX-P4641 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1 |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2 |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
| Formula | C6428H9912N1694O1987S46 |
Description of Stable Isotope Labeled Adalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade
General information about Adalimumab
Adalimumab is a recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases. Check for active clinical trials using this agent.
Related products
Antigen
Hemagglutinin(HA) Japan
PX-P4417 210€
Antigen
Hemagglutinin(HA) Texas
PX-P4604 210€
Antigen
Hemagglutinin(HA) Maryland
PX-P4443 210€
Antigen
Hemagglutinin(HA) Connecticut
PX-P4605 210€
Biosimilar
Reviews
Il n’y a pas encore d’avis.